Press Releases Navamedic ASA

Equities

Market Closed - Oslo Bors Other stock markets 08:15:00 10/05/2024 pm IST			5-day change	1st Jan Change
33.1 ^NOK	-0.90%		+1.53%	-9.81%

06/05	Navamedic Rolls Out Erectile Dysfunction Drug in Sweden	MT
30/04	Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Navamedic ASA: Broad launch for Eroxon® in Sweden today	06/05	AQ
Navamedic ASA: Annual Report 2023	30/04	AQ
Navamedic Q1 2024: Successful product launch and steady operational progress	30/04	AQ
Navamedic ASA: Invitation to 2024 1st quarter presentation	23/04	AQ
Disclosure in NAVAMEDIC ASA	21/03	AQ
Major shareholder disclosure in Navamedic ASA	18/03	AQ
Navamedic ASA - Mandatory notification of trade by primary insider	15/03	AQ
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options	15/03	AQ
Navamedic welcomes new shareholders	13/03	AQ
Navamedic ASA - Notification of Major Holdings	13/03	AQ
Navamedic ASA: Notification of major shareholding and mandatory notification of trade	13/03	AQ
Contemplated block sale of existing shares in Navamedic ASA	12/03	AQ
Navamedic ASA: Mandatory notification of trade	23/02	AQ
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives	15/02	AQ
Navamedic ASA: Invitation to 2023 4th quarter presentation	13/02	AQ
Navamedic ASA launches Eroxon®	12/02	AQ
Navamedic ASA, Renewed contract signed with Vitaflo International Limited	22/12	AQ
Navamedic ASA: Renewed contract signed with Vitaflo International Limited	21/12	AQ
Navamedic and Orion Corporation sign non-binding term sheet for Flexilev® in Europe	13/12	AQ
Navamedic ASA: Record high quarter with above 50 percent growth	01/11	AQ

No results for this search